Key Insights

Highlights

Treatment Research

3 treatments under study, led by Compressive Garments Class Ii

Research Leaders

6 sponsors active, led by Region Skane

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT04061967Not ApplicableRecruiting

Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.

NCT05469945Not ApplicableRecruiting

Lymphedema After Gyneco-oncologic Treatment

NCT05835947Unknown

Anal Cancer Risk In Women

Showing all 3 trials

Research Network

Common Treatments

  • Compressive Garments Class Ii1
  • Dual Pathology1
  • Sending Of Screening Summon1

Active Sponsors

  • Region Skane1
  • University Hospital, Ghent1
  • Karolinska Institutet1
  • Kom Op Tegen Kanker1
  • Imperial College London1

Top Investigators

Related Conditions

  • Genital Diseases Female1
  • Uterine Cervical Neoplasm1
  • Neoplasms By Site1
  • Anal Cancer1
  • Uterine Neoplasms1

Activity Timeline